Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Cardiac Sciences Guidelines
    • Depression and...

    Depression and coronary heart disease: 2018 ESC Guideline

    Written by Dr. Kamal Kant Kohli Kohli Published On 2019-02-05T19:00:16+05:30  |  Updated On 5 Feb 2019 7:00 PM IST
    Depression and coronary heart disease: 2018 ESC Guideline

    The European Society of Cardiology (ESC) has released its 2018 Practice Guidelines on Depression and coronary heart disease. Major depression is a highly prevalent condition, affecting approximately 10% of the population. It has been consistently associated with increased risk of coronary heart disease (CHD). The guidelines have appeared in European Heart Journal.


    Evidence from both experimental and epidemiological studies indicates that there is a bidirectional association between depression and CHD. Depression is very common in patients with CHD and is an independent risk factor for poorer CHD outcomes.


    There are several treatments options for the CHD patient with depression, from medications to various forms of psychotherapy, to exercise and stress management approaches. Although treatment of depression has not been shown to improve cardiovascular outcomes in CHD patients, depression should still be addressed if severe enough, in order to promote patient wellness and QoL.


    Key Recommendations are -

    • Clinicians should be aware of the high prevalence of depression in CHD patients. Screening for depression is recommended if patients have access to adequate care support systems

    • Patients with positive screening results should be referred to a qualified health care provider in the management of depression

    • Non-pharmacologic interventions such as exercise and psychotherapy should be considered as additional treatment options for CHD patients

    • Harmonization of care between healthcare providers is essential in patients with combined CHD and depression

    • Tricyclics should be avoided in this patient population.





    Pharmacological management of depression in patients with coronary heart disease































































    Drug classification/ generic nameIndicationCardiovascular adverse effectsOther adverse effects
    Selective serotonin reuptake inhibitors
    Fluoxetine Sertraline Paroxetine Fluvoxamine Citalopram Escitalopram

    • Agents of choice in CHD

    • Sertraline: agent of choice in post-MI patients

    • Citalopram: should be used with caution in patients at high risk of QTc prolongation or Torsades de Pointes such as those with congestive heart failure, recent MI, bradyarrhythmias hypokalaemia or hypomagnesaemia, congenital long QT syndrome.




    • Fewer to no anticholinergic and cardiac effects

    • Concomitant use with aspirin and other antiplatelet/anticoagulation treatment may increase risk bleeding especially in the elderly

    • Citalopram is associated with dose-related QTc interval prolongation


    Nausea, diarrhoea, headache, insomnia, agitation, loss of libido, delayed ejaculation, and erectile dysfunction
    Tricyclic antidepressants
    Imipramine Doxepine Amoxapine Nortriptyline Amitriptyline

    • Avoid in CHD, conduction defects, congestive heart failure, and elderly

    • Contraindicated in post-MI patients




    • Increase heart rate

    • Prolongation of the PR interval, QRS duration and QTc interval, and a flattening of the T wave on the electrocardiogram

    • Orthostatic hypotension

    • Abrupt withdraw may associated with increased risk of arrythmias


    Anticholinergic effects: dry mouth, constipation, memory problems, confusion, blurred vision, sexual dysfunction, and decreased urination, and memory impairment especially in the elderly
    Serotonin-norepinephrine reuptake inhibitors
    Desvenlafaxine Duloxetine Levomilnacipran Milnacipran Venlafaxine

    • Venlafaxine: avoid in patients at high risk of malignant ventricular arrhythmias or with uncontrolled hypertension




    • Fewer to no cardiac effects

    • Have been associated with a dose dependent increase in blood pressure and heart rate

    • Regular blood pressure monitoring

    • Venlafaxine: Minor degree of QTc prolongation


    Dizziness, constipation, dry mouth, headache, changes in sleep, or more rarely a serotonin syndrome, with restlessness, shivering, and sweating
    Antidepressants with novel mechanisms of action
    Buproprion

    • Smoking cessation in CHD patients




    • Possible increases in blood pressure

    • Minor degree of QTc prolongation


    Weight loss, restlessness, high doses can rarely cause seizures
    Mirtazapine

    • Use with caution in CHD and post-MI patients




    • Mild orthostatic hypotension

    • Minor degree of QTc prolongation


    Sweating and shivering, tiredness, strange dreams, dyslipidemia, weight gain, anxiety, and agitation
    Trazodone

    • Use with caution in CHD, patients with atrioventricular conductions blocks or other conduction disorders and post-MI patients




    • Orthostatic hypotension

    • Minor to low degree of QTc prolongation


    Rarely, it can cause priapism


    For further reference log on to : https://doi.org/10.1093/eurheartj/ehy913
    CADCoronary artery diseasecoronary heart diseasedepressionEuropean Heart JournalExercisemanagementpatientspsychotherapytricyclics

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Dr. Kamal Kant Kohli Kohli
    Dr. Kamal Kant Kohli Kohli
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok